nodes	percent_of_prediction	percent_of_DWPC	metapath
Aspartame—Bortezomib—hematologic cancer	0.638	1	CrCtD
Aspartame—Nateglinide—Bortezomib—hematologic cancer	0.102	0.341	CrCrCtD
Aspartame—Lacosamide—Bortezomib—hematologic cancer	0.0969	0.324	CrCrCtD
Aspartame—Phenacemide—Vorinostat—hematologic cancer	0.0773	0.258	CrCrCtD
Aspartame—L-Phenylalanine—Melphalan—hematologic cancer	0.0227	0.076	CrCrCtD
Aspartame—SLC22A8—Mercaptopurine—hematologic cancer	0.0191	0.472	CbGbCtD
Aspartame—SLC22A11—Methotrexate—hematologic cancer	0.0108	0.266	CbGbCtD
Aspartame—SLC22A8—Methotrexate—hematologic cancer	0.00625	0.154	CbGbCtD
Aspartame—SLC22A6—Methotrexate—hematologic cancer	0.00436	0.108	CbGbCtD
Aspartame—TRPV1—Transmembrane transport of small molecules—SGK1—hematologic cancer	9.44e-05	0.00412	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	9.44e-05	0.00412	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	9.44e-05	0.00412	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HDAC10—hematologic cancer	9.28e-05	0.00405	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CNR2—hematologic cancer	9.03e-05	0.00394	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PDE4B—hematologic cancer	9.03e-05	0.00394	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—RAC2—hematologic cancer	8.88e-05	0.00388	CbGpPWpGaD
Aspartame—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—hematologic cancer	8.81e-05	0.00385	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	8.5e-05	0.00371	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ARHGEF12—hematologic cancer	8.49e-05	0.00371	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—ADCY7—hematologic cancer	8.49e-05	0.00371	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ARHGEF1—hematologic cancer	8.28e-05	0.00361	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	8.14e-05	0.00355	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CCL3—hematologic cancer	7.76e-05	0.00339	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—AQP9—hematologic cancer	7.69e-05	0.00336	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PTHLH—hematologic cancer	7.68e-05	0.00335	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PTGER4—hematologic cancer	7.47e-05	0.00326	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	7.46e-05	0.00326	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGRN—hematologic cancer	7.42e-05	0.00324	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCL17—hematologic cancer	7.42e-05	0.00324	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCR5—hematologic cancer	7.29e-05	0.00318	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	7.25e-05	0.00317	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LEF1—hematologic cancer	7.16e-05	0.00313	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—FXYD6—hematologic cancer	7.15e-05	0.00312	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GNA13—hematologic cancer	7.04e-05	0.00307	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TIAM1—hematologic cancer	6.92e-05	0.00302	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	6.82e-05	0.00298	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	6.79e-05	0.00297	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—CCL2—hematologic cancer	6.74e-05	0.00294	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—JAK3—hematologic cancer	6.71e-05	0.00293	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCR4—hematologic cancer	6.6e-05	0.00288	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—NUP98—hematologic cancer	6.44e-05	0.00281	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCR7—hematologic cancer	6.44e-05	0.00281	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL13—hematologic cancer	6.44e-05	0.00281	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL3—hematologic cancer	6.36e-05	0.00278	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NCOR2—hematologic cancer	6.35e-05	0.00277	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	6.29e-05	0.00275	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CRKL—hematologic cancer	6.27e-05	0.00274	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL3RA—hematologic cancer	6.27e-05	0.00274	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	6.25e-05	0.00273	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—NUP214—hematologic cancer	6.21e-05	0.00271	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—RASGRP1—hematologic cancer	6.16e-05	0.00269	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	6.08e-05	0.00266	CbGpPWpGaD
Aspartame—Lacosamide—CA9—hematologic cancer	6.07e-05	0.523	CrCbGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	6.05e-05	0.00264	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RGS2—hematologic cancer	6.05e-05	0.00264	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TRH—hematologic cancer	5.98e-05	0.00261	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CMA1—hematologic cancer	5.98e-05	0.00261	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TRIO—hematologic cancer	5.98e-05	0.00261	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—NUP98—hematologic cancer	5.93e-05	0.00259	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—AQP9—hematologic cancer	5.87e-05	0.00256	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGO2—hematologic cancer	5.85e-05	0.00256	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SPHK1—hematologic cancer	5.85e-05	0.00256	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—S100A10—hematologic cancer	5.83e-05	0.00255	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LPAR1—hematologic cancer	5.79e-05	0.00253	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HDAC9—hematologic cancer	5.79e-05	0.00253	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—H3F3B—hematologic cancer	5.74e-05	0.00251	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—NUP214—hematologic cancer	5.72e-05	0.0025	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—GRB2—hematologic cancer	5.54e-05	0.00242	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—FXYD6—hematologic cancer	5.45e-05	0.00238	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.42e-05	0.00237	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	5.42e-05	0.00237	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CNR2—hematologic cancer	5.33e-05	0.00233	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDE4B—hematologic cancer	5.33e-05	0.00233	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGF19—hematologic cancer	5.29e-05	0.00231	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RAC2—hematologic cancer	5.25e-05	0.00229	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—DKK1—hematologic cancer	5.2e-05	0.00227	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—STAT5B—hematologic cancer	5.16e-05	0.00226	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	5.1e-05	0.00223	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADCY7—hematologic cancer	5.01e-05	0.00219	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CSF2—hematologic cancer	4.95e-05	0.00216	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—AQP9—hematologic cancer	4.9e-05	0.00214	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—XIAP—hematologic cancer	4.88e-05	0.00213	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	4.83e-05	0.00211	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	4.79e-05	0.00209	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PRKCG—hematologic cancer	4.77e-05	0.00208	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—JAK1—hematologic cancer	4.77e-05	0.00208	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SMARCA4—hematologic cancer	4.75e-05	0.00208	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SH2B3—hematologic cancer	4.75e-05	0.00208	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GZMB—hematologic cancer	4.72e-05	0.00206	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CTNNA1—hematologic cancer	4.61e-05	0.00201	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EIF4EBP1—hematologic cancer	4.59e-05	0.002	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HSPB1—hematologic cancer	4.59e-05	0.002	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCL3—hematologic cancer	4.59e-05	0.002	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—FXYD6—hematologic cancer	4.55e-05	0.00199	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.55e-05	0.00199	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTHLH—hematologic cancer	4.53e-05	0.00198	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SDC1—hematologic cancer	4.53e-05	0.00198	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—NUP98—hematologic cancer	4.53e-05	0.00198	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL2RA—hematologic cancer	4.46e-05	0.00195	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—S100A10—hematologic cancer	4.45e-05	0.00194	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ATP4A—hematologic cancer	4.42e-05	0.00193	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SGK1—hematologic cancer	4.42e-05	0.00193	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ANXA2—hematologic cancer	4.42e-05	0.00193	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTGER4—hematologic cancer	4.41e-05	0.00193	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LCK—hematologic cancer	4.39e-05	0.00192	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—NUP214—hematologic cancer	4.36e-05	0.00191	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—H3F3A—hematologic cancer	4.3e-05	0.00188	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRKCZ—hematologic cancer	4.18e-05	0.00183	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	4.13e-05	0.00181	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PARP1—hematologic cancer	4.04e-05	0.00176	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	4e-05	0.00175	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	3.98e-05	0.00174	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FBXW7—hematologic cancer	3.98e-05	0.00174	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCR4—hematologic cancer	3.9e-05	0.0017	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HDAC2—hematologic cancer	3.9e-05	0.0017	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	3.89e-05	0.0017	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CBL—hematologic cancer	3.8e-05	0.00166	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.8e-05	0.00166	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—NUP98—hematologic cancer	3.78e-05	0.00165	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL3—hematologic cancer	3.76e-05	0.00164	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CG—hematologic cancer	3.71e-05	0.00162	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—S100A10—hematologic cancer	3.71e-05	0.00162	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTPN1—hematologic cancer	3.7e-05	0.00161	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	3.68e-05	0.00161	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PTPN11—hematologic cancer	3.65e-05	0.00159	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—NUP214—hematologic cancer	3.64e-05	0.00159	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RASGRP1—hematologic cancer	3.64e-05	0.00159	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HSP90AA1—hematologic cancer	3.62e-05	0.00158	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SYK—hematologic cancer	3.62e-05	0.00158	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CREB1—hematologic cancer	3.54e-05	0.00154	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—STAT1—hematologic cancer	3.5e-05	0.00153	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCC3—hematologic cancer	3.49e-05	0.00153	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CCL2—hematologic cancer	3.46e-05	0.00151	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	3.45e-05	0.00151	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL6R—hematologic cancer	3.45e-05	0.00151	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ANXA2—hematologic cancer	3.37e-05	0.00147	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP4A—hematologic cancer	3.37e-05	0.00147	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SGK1—hematologic cancer	3.37e-05	0.00147	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—MAP2K1—hematologic cancer	3.29e-05	0.00144	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GRB2—hematologic cancer	3.27e-05	0.00143	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CD—hematologic cancer	3.27e-05	0.00143	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDGFA—hematologic cancer	3.26e-05	0.00142	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	3.24e-05	0.00142	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KITLG—hematologic cancer	3.22e-05	0.0014	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	3.19e-05	0.0014	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—STAT5A—hematologic cancer	3.14e-05	0.00137	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CDKN2B—hematologic cancer	3.12e-05	0.00136	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3R1—hematologic cancer	3.08e-05	0.00135	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	3.08e-05	0.00134	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	3.03e-05	0.00133	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—NUP98—hematologic cancer	3.02e-05	0.00132	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CD86—hematologic cancer	3.01e-05	0.00132	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—JAK2—hematologic cancer	3e-05	0.00131	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HES1—hematologic cancer	2.97e-05	0.0013	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NCOR1—hematologic cancer	2.95e-05	0.00129	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.93e-05	0.00128	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGF1—hematologic cancer	2.92e-05	0.00128	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CSF2—hematologic cancer	2.92e-05	0.00128	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.91e-05	0.00127	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FOXO1—hematologic cancer	2.88e-05	0.00126	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDGFRB—hematologic cancer	2.87e-05	0.00126	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.85e-05	0.00124	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CB—hematologic cancer	2.85e-05	0.00124	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDGFRA—hematologic cancer	2.83e-05	0.00124	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—JAK1—hematologic cancer	2.82e-05	0.00123	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRKCG—hematologic cancer	2.82e-05	0.00123	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.81e-05	0.00123	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.81e-05	0.00123	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.81e-05	0.00123	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.66e-05	0.00116	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL2RA—hematologic cancer	2.63e-05	0.00115	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL2—hematologic cancer	2.61e-05	0.00114	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TERT—hematologic cancer	2.6e-05	0.00114	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDGFB—hematologic cancer	2.54e-05	0.00111	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.54e-05	0.00111	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.54e-05	0.00111	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.53e-05	0.00111	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TSC2—hematologic cancer	2.48e-05	0.00108	CbGpPWpGaD
Aspartame—Lisinopril—ABCB1—hematologic cancer	2.45e-05	0.211	CrCbGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.44e-05	0.00106	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGFR3—hematologic cancer	2.39e-05	0.00104	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.37e-05	0.00104	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MAPK14—hematologic cancer	2.37e-05	0.00103	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ESR1—hematologic cancer	2.32e-05	0.00101	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.3e-05	0.001	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FN1—hematologic cancer	2.29e-05	0.001	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NFKBIA—hematologic cancer	2.27e-05	0.000989	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—BAD—hematologic cancer	2.27e-05	0.000989	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOTCH1—hematologic cancer	2.24e-05	0.00098	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.23e-05	0.000975	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.22e-05	0.000971	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.22e-05	0.000968	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CD80—hematologic cancer	2.2e-05	0.00096	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CG—hematologic cancer	2.19e-05	0.000958	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KIT—hematologic cancer	2.19e-05	0.000958	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—NRAS—hematologic cancer	2.19e-05	0.000958	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.19e-05	0.000955	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.17e-05	0.000948	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTPN11—hematologic cancer	2.16e-05	0.000941	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.13e-05	0.00093	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—MAPK3—hematologic cancer	2.1e-05	0.000918	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CREB1—hematologic cancer	2.09e-05	0.000912	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—BRAF—hematologic cancer	2.06e-05	0.000901	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCL2—hematologic cancer	2.04e-05	0.000892	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL6R—hematologic cancer	2.04e-05	0.00089	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CREBBP—hematologic cancer	2.03e-05	0.000888	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.03e-05	0.000888	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MAP2K1—hematologic cancer	1.94e-05	0.000848	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.94e-05	0.000845	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CD—hematologic cancer	1.93e-05	0.000842	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.92e-05	0.000838	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—KRAS—hematologic cancer	1.89e-05	0.000825	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.86e-05	0.000814	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.85e-05	0.000808	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGF2—hematologic cancer	1.85e-05	0.000807	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3R1—hematologic cancer	1.82e-05	0.000795	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.81e-05	0.000792	CbGpPWpGaD
Aspartame—Enalapril—ABCB1—hematologic cancer	1.8e-05	0.155	CrCbGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.78e-05	0.000776	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—JAK2—hematologic cancer	1.77e-05	0.000773	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CA—hematologic cancer	1.73e-05	0.000758	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MDM2—hematologic cancer	1.73e-05	0.000755	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MTOR—hematologic cancer	1.68e-05	0.000734	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CB—hematologic cancer	1.68e-05	0.000734	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.67e-05	0.000729	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.62e-05	0.000709	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.62e-05	0.000706	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—HRAS—hematologic cancer	1.61e-05	0.000701	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CDKN1B—hematologic cancer	1.58e-05	0.000689	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CASP3—hematologic cancer	1.55e-05	0.000675	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL2—hematologic cancer	1.54e-05	0.000674	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL6—hematologic cancer	1.54e-05	0.000671	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCND1—hematologic cancer	1.51e-05	0.000657	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—JUN—hematologic cancer	1.5e-05	0.000656	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CDKN1A—hematologic cancer	1.46e-05	0.000636	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTEN—hematologic cancer	1.45e-05	0.000634	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MAPK8—hematologic cancer	1.42e-05	0.000621	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AKT1—hematologic cancer	1.42e-05	0.000619	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.39e-05	0.000608	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EP300—hematologic cancer	1.39e-05	0.000605	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.36e-05	0.000592	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.36e-05	0.000592	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SRC—hematologic cancer	1.35e-05	0.000588	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—VEGFA—hematologic cancer	1.31e-05	0.000573	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—STAT3—hematologic cancer	1.3e-05	0.000567	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NRAS—hematologic cancer	1.3e-05	0.000566	CbGpPWpGaD
Aspartame—Nateglinide—ALB—hematologic cancer	1.29e-05	0.111	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—MAPK3—hematologic cancer	1.24e-05	0.000542	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MYC—hematologic cancer	1.21e-05	0.000527	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TGFB1—hematologic cancer	1.2e-05	0.000526	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.19e-05	0.000519	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.13e-05	0.000494	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KRAS—hematologic cancer	1.12e-05	0.000487	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ALB—hematologic cancer	1.11e-05	0.000486	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CA—hematologic cancer	1.02e-05	0.000448	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TP53—hematologic cancer	9.91e-06	0.000433	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HRAS—hematologic cancer	9.48e-06	0.000414	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL6—hematologic cancer	9.08e-06	0.000396	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	9.06e-06	0.000396	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	8.48e-06	0.00037	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AKT1—hematologic cancer	8.37e-06	0.000366	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.56e-06	0.00033	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	7.08e-06	0.000309	CbGpPWpGaD
